Heart failure with low cardiac output and risk of development of lesions in the cerebral white matter

European Journal of General Medicine

Volumn 2, Issue 2, 2005, Pages 56-61

  Koçer, Abdulkadir ^a,e   Esen, Özlem ^b   Ince, Nurhan ^c   Gözke, Eren ^a   Karakaya, Osman ^d   Barutçu, Irfan ^d  

^a Training and Research Hospital   (Turkey)

^b MEMORIAL HOSPITAL   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

^d Department of Anesthesiology   (Turkey)

^e Education and Research Hospital   (Turkey)

Author keywords

Atrial fibrilation; Cardiac failure; Leukoaraiosis; Risk factors; White matter

Indexed keywords

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BRAIN DAMAGE; CARDIOVASCULAR RISK; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FORWARD HEART FAILURE; HEART ATRIUM FIBRILLATION; HUMAN; LEUKOARAIOSIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; RISK ASSESSMENT; RISK FACTOR; STROKE; WHITE MATTER;

EID: 28844461786     PISSN: 13043889     EISSN: None     Source Type: Journal    
DOI: 10.29333/ejgm/82270     Document Type: Article

References (28)

1. Breteler MMB, van Swieten JC, Bots ML et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology 1994;44:1246-52
2. Liao D, Cooper L, Cai J et al. Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The AIRIC Study. Atherosclerosis Risk in Communities Study. Stroke 1996;27:2262-70
3. Longstreth W Jr, Manolio TA, Arnold A et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 1996;27:1274-82
4. Breteler MMB, van Amerongen NM, van Swieten JC et al. Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging. The Rotterdam Study. Stroke 1994;25:1109-15
5. Skoog I, Lernfelt B, Landahl T et al. 15-year longitudinal study of blood pressure and dementia. Lancet 1996;347:1141-5
6. De Groot JC, De Leeuw F-E, Breteler MMB. Cognitive correlates of cerebral white matter changes. J Neural Transm 1998;53:41-69
7. De Groot JC, De Leeuw F-E, Oudkerk M et al. Cerebral white matter lesions and cognitive function. The Rotterdam Scan Study. Ann Neurol 2000;47:145-51
8. Skoog I. The relationship between blood pressure and dementia: a review. Biomed Pharmacother 1997;51:367-75
9. Roman GC. Prom UBOs to Binswanger's disease. Impact of magnetic resonance imaging on vascular dementia research. Stroke 1996;27:1269-73
10. Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: a review. Stroke 1997;28:652-9
11. De Leeuw F-F, Do Groot JC, Oudkerk M, et al. A follow-up study of blood pressure and cerebral white matter lesions. Ann Neurol 1999;46:827-3
12. Lip GY, Beevers DC, Coope JR. ABC of atrial fibrillation. Atrial fibrillation in general and hospital practice. BMJ 1996;312:175-8
13. De Leeuw F-F, Do Groot JC, Oudkerk M, et al. Atrial fibrilation and the risk of white matter lesions. Neurology 2000;54:1795-1800
14. Roine RO, Raininko R, Erkinjuntti T, Ylikoski A, Kaste M. Magnetic resonance imaging findings associated with cardiac arrest. Stroke 1993;24:1005-14
15. Sakakibara R, Hattori T, Uchiyama T, Yamanishi T. Urinary function in elderly people with and without leukoaraiosis: relation to cognitive and gait function. J Neurol Neurosurg Psychiatry 1999;67:658-60
16. Inzitari D. Leukoaraiosis: an independent risk factor for stroke? Stroke 2003;34:2067-71
17. Vermeer SE, Hollander M, van Dijk EJ et al. Rotterdam Scan Study. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke 2003;34:1126-9
18. Wiszniewska M, Devuyst G, Bogousslavsky J, Ghika J, van Melle G. What is the significance of leukoaraiosis in patients with acute ischemic stroke? Arch Neurol 2000;57(7):967-73
19. Meyer JS, Rauch GM, Rauch RA, Haque A, Crawford K. Cardiovascular and other risk factors for Alzheimer's disease and vascular dementia. Ann NY Acad Sci 2000;903:411-23
20. Yamauchi H, Fukuda H, Oyanagi C. Significance of white matter high intensity lesions as a predictor of stroke from arteriolosclerosis. J Neurol Neurosurg Psychiatry 2002;72:576-82
21. Jorgensen HS, Nakayama H, Raaschou HO, Olsen TS. Leukoaraiosis in stroke patients. The Copenhagen Stroke Study. Stroke 1995;26:588-92
22. Streifler JY, Eliasziw M, Benavente OR et al. North American Symptomatic Carotid Endarterectomy Trial Group. Development and progression of leukoaraiosis in patients with brain ischemia and carotid artery disease. Stroke 2003;34:1913-6
23. Kohara K, Zhao B, Jiang Yet al. Relation of left ventricular hypertrophy and geometry to asymptomatic cerebro-vascular damage in essential hypertension. Am J Cardiol 1999;83:367-70
24. Gorter JW. Stroke Prevention In Reversible Ischemic Trial (SPIRIT) and European Atrial Fibrillation Trial (EAFT) study groups. Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors. Neurology 1999;53:1319-27
25. Lip GY, Beevers DC, Singh SF, Watson RD. ABC of atrial fibrillation. Aetiology, pathophysiology, and clinical features. BMJ 1995;311:1425-28
26. Meyer JS, Terayama Y, Konno S, Akiyama H, Margishvili GM, Mortel KF. Risk factors for cerebral degenerative changes and dementia. Eur Neurol 1998;39(Suppl)1:7-16
27. Tarvonen-Schroder S, Roytta M, Raiha I, Kurki T, Rajala T, Sourander L. Clinical features of leuko-araiosis. J Neurol Neurosurg Psychiatry 1996;60:431-6
28. Tarvonen-Schroder S, Kurki T, Raiha I, Sourander L. Leukoaraiosis and cause of death: a five year follow up. J Neurol Neurosurg Psychiatry 1995;58:586-9